Confirmation of cocaine use during pregnancy: A critical review

Therapeutic Drug Monitoring

Volumn 23, Issue 4, 2001, Pages 347-353

  Ursitti, Franca ^a   Klein, Julia ^a   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

COCAINE DEPENDENCE; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG URINE LEVEL; HAIR; HUMAN; MECONIUM; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW;

COCAINE; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SUBSTANCE ABUSE DETECTION;

EID: 0034897145     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200108000-00005     Document Type: Review

References (56)

1. Effect of cocaine use on the fetus
2. Urine drug screening in mothers and newborns
3. Maternal and neonatal characteristics following exposure to cocaine in Toronto
4. Drug use in metropolitan Toronto (1997) 50pp
5. Clinical pharmacology and toxicology of cocaine
6. The pharmacology of cocaine smoking in humans
7. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting) or smoking
8. Urinary excretion of cocaine, benzoylecgonine and ecgonine methyl ester in humans
9. Brain concentrations of cocaine and benzoylecgonine in fatal cases
10. Perinatal cerebral infarction and maternal cocaine use
11. Cocaine intoxication in breastfed infant
12. Determination of gestational cocaine exposure by hair analysis
13. Fetal distribution of cocaine: Case analysis
14. Transfer of cocaine and benzoylecgonine across the perfused human placental cotyledon
15. Metabolism of cocaine in man
16. Excretion of cocaine and its metabolites in man
17. Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterases
18. The urinary excretion of cocaine and metabolites in humans: A kinetic analysis of published data
19. Effects of maternal marijuana and cocaine use on fetal growth
20. Cocaine use during pregnancy: Prevalence and correlates
21. Pyrolysis and volatilization of cocaine
22. Determinants of recall and recall bias in studying drug and chemical exposure during pregnancy
23. Concordance of three measures of cocaine use in an arrestee population: Hair, urine and self-report
24. Cocaine: Analysis, pharmacokinetics and metabolic disposition
25. Hair zinc and dietary zinc intake during pregnancy and puerperium
26. Environmental exposure to cadmium and human birthweight
27. Axial distribution of arsenic in individual human hairs by solid sampling graphite furnace AAS
28. Dose-response analysis of infant prenatally exposed to methylmercury: An application of a single compartment model to single-strand hair analysis
29. Accumulation of cocaine in maternal and fetal hair: The dose-response curve
30. Detection of cocaine metabolite in perspiration stain, menstrual blood stain and hair
31. Determination of cocaine in human hair by gas chromatography-mass spectrometry
32. Radioimmunological determination of cocaine in human hair
33. Hair analysis for drug abuse: I. Determination of methamphetamine and amphetamine in hair by stable isotope dilution gas chromatography/mass spectrometry method
34. Testing human hair for drugs of abuse. I. Individual dose and time profile of morphine and codeine in plasma, saliva, urine and beard compared with drug induced effects on pupils and behavior
35. Testing human hair for drugs of abuse. III. Identification of heroin and 6-acetylmorphine as indicators of heroin use
36. Incorporation of isotopically labeled cocaine and metabolites into human hair. 1. Dose-response relationships
37. Time course of cocaine in rabbit hair
38. The validity of hair analysis for detecting cocaine and heroin use among addicts
39. Integrated use of hair analysis to investigate the physical fitness to obtain the driving license: A casework study
40. Distribution and visualization of drugs in hair by infrared microscopy
41. Dose-response effect of fetal cocaine exposure on newborn neurologic function
42. Dose-response effect of cocaine on newborn head circumference
43. Hair analysis of cocaine: Differentiation between systemic exposure and external contamination
44. Drug screening of newborns by meconium analysis: A large-scale prospective epidemiologic study
45. Adaptation of the meconium drug test for mass screening
46. Measurement of gestational cocaine exposure: Sensitivity of infants' hair, meconium and urine
47. Assessment of in utero exposure to cocaine: Radioimmunoassay testing for BZ in meconium, neonatal hair and maternal hair
48. Meconium analysis for cocaine: A validation study and comparison with paired urine analysis
49. m-hydroxybenzoylecgonine: An important contributor to the immuno-reactivity in assays for benzoylecgonine in meconium
50. Drug screening of meconium in infants of drug-dependent mothers: An alternative to urine testing
51. Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions
52. Determination of cocaine and its major metabolite, benzoylecgonine in amniotic fluid, umbilical cord blood, umbilical cord tissue and neonatal urine. A case study
53. Kinetics of drug transfer to the fetus
54. Monitoring drug use with a sweat patch
55. Sweat testing for heroin, cocaine and metabolite